Search - tctmd.com

Displaying 321 - 340 of 388

Sort: Relevancy | Date

News Conference News ACC 2018

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

Caitlin E. Cox

February 28, 2018

News Daily News

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

L.A. McKeown

February 09, 2018

News Daily News

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

Shelley Wood

February 01, 2018

News Daily News

Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk

Michael O'Riordan

January 25, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Gestational Diabetes Increases Risk of Ischemic Heart Disease

Michael O'Riordan

January 16, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Michael O'Riordan

December 25, 2017

News Daily News

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Michael O'Riordan

December 12, 2017

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Caitlin E. Cox

December 12, 2017

News Daily News

Better ECG Interpretation Criteria Needed for Professional Basketball Players, Study Suggests

Todd Neale

December 06, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

CVD Risk for Women Rises After Gestational Diabetes

Yael L. Maxwell

October 16, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Daily News

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

Todd Neale

September 22, 2017

News Industry News

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

September 15, 2017

Advertisement

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Gestational Diabetes Increases Risk of Ischemic Heart Disease

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Better ECG Interpretation Criteria Needed for Professional Basketball Players, Study Suggests

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Statins and Diabetes: Causal Link Reinforced in New Analysis

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

CVD Risk for Women Rises After Gestational Diabetes

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Secondary Prevention Lagging Behind in Women With Established Coronary Disease

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content